123 related articles for article (PubMed ID: 9032534)
21. Apoptosis in renal cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors.
Todd D; Yang G; Brown RW; Cao J; D'Agati V; Thompson TS; Truong LD
Hum Pathol; 1996 Oct; 27(10):1012-7. PubMed ID: 8892583
[TBL] [Abstract][Full Text] [Related]
22. Does the immunophenotype of renal cell carcinoma correlate with its clinical stage?
Kaiser U; Hansmann ML; Papadopoulos I
Urol Int; 1991; 47(4):194-8. PubMed ID: 1781102
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
[TBL] [Abstract][Full Text] [Related]
24. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
[TBL] [Abstract][Full Text] [Related]
25. DNA content, nuclear grading and early tumor progression in renal cell cancer: a prospective study on frozen specimens.
Cavazzana AO; Prayer-Galetti T; Sangiorgio A; Fassina AS; Panozzo M; Zucchetta P; Pagano F
Eur Urol; 1992; 22(4):311-5. PubMed ID: 1490509
[TBL] [Abstract][Full Text] [Related]
26. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
Mehdi MZ; Nagi AH; Naseem N
Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study.
Rudolph P; Gloeckner K; Parwaresch R; Harms D; Schmidt D
Hum Pathol; 1998 Aug; 29(8):791-800. PubMed ID: 9712419
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
29. [Tumor heterogeneity of renal cell carcinoma as analyzed by flow cytometry].
Nagamori S
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):593-600. PubMed ID: 2374332
[TBL] [Abstract][Full Text] [Related]
30. Histopathologic prognostic indicators for renal cell carcinoma.
Delahunt B
Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
[TBL] [Abstract][Full Text] [Related]
31. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
33. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
35. Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature.
Strohmeyer T; Ackermann R
Urol Int; 1991; 47(4):203-12. PubMed ID: 1781104
[TBL] [Abstract][Full Text] [Related]
36. Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma.
Papadopoulos I; Rudolph P; Weichert-Jacobsen K
Eur Urol; 1997; 32(1):110-7. PubMed ID: 9266242
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
39. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
40. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
